D-1359-2016 Class II Terminated
FDA drug recall D-1359-2016 was initiated by Hospira Inc. on Jun 23, 2016 and is designated Class II. Reason for recall: Crystallization: Product contains particulate identified to be crystallized active ingredient. The recall status is terminated (terminated Aug 31, 2018). Affected quantity: 373,850 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 20, 2016
- Initiation Date
- Jun 23, 2016
- Termination Date
- Aug 31, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 373,850 tubes
Product description
Diazepam Injection USP 10mg/2mL (5 mg/mL, 2 mL), Rx only, Hospira Inc. Lake Forest, IL 60045, NDC 0409-1273-32
Reason for recall
Crystallization: Product contains particulate identified to be crystallized active ingredient.
Distribution pattern
Nationwide
Code information
Lot #: 52610LL, Exp. 01 OCT 2016; Lot #: 57660LL, Exp. 01 MAR 2017
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1359-2016
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Hospira Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.